Prognostic implication of YY1 and CP2c expression in patients with primary breast cancer
Authors:
Preprint
- 2 February 2023
- preprint
- Published by Springer Nature in Research Square
Abstract
Background YY1 is transcription factor that regulates differential epigenetic pathways and protein modifications. CP2c is transcription factor that functions as oncogene to regulate cancer cell proliferation. YY1 is known to interact with CP2c to suppress CP2c’s transcriptional activity. However, it is unknown whether YY1 has prognostic significance in breast cancer. Thus, we aimed to investigate YY1 and CP2c expression in breast cancer and prognostic implications. Methods Clinical information and tissues were obtained from 491 patients with invasive breast cancer. YY1 expression was evaluated using immunohistochemical staining and patients were divided into two groups according to H-score. Western blot and RT-PCR assays were used for quantifications of YY1 and CP2c mRNA and protein expression. Results Of 491 patients with breast cancer, 138 patients showed YY1 overexpression. Luminal subtype, and early stage were associated with overexpression. After follow-up of 68 months, YY1 overexpression was found to be associated with better prognosis. In Cox proportional hazards model, YY1 overexpression functioned as independent prognostic factor after adjustment of ER/HER2 status and tumor size. Quantitative analysis of YY1 and CP2c protein expression in tumor revealed negative correlation between them. Conclusions YY1 overexpression is a favorable prognostic biomarker in patients with breast cancer, and it has negative correlation with CP2c.Keywords
All Related Versions
This publication has 31 references indexed in Scilit:
- Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013Annals of Oncology, 2013
- Cooperation of deregulated Notch signaling and Ras pathway in human hepatocarcinogenesisJournal of Molecular Histology, 2011
- YY1 Tethers Xist RNA to the Inactive X Nucleation CenterCell, 2011
- Yin Yang 1 positively regulates BRCA1 and inhibits mammary cancer formationOncogene, 2011
- Late SV40 factor: A key mediator of Notch signaling in human hepatocarcinogenesisWorld Journal of Gastroenterology, 2011
- The role of YY1 in reduced HP1α gene expression in invasive human breast cancer cellsBreast Cancer Research, 2009
- The fold recognition of CP2 transcription factors gives new insights into the function and evolution of tumor suppressor protein p53Cell Cycle, 2008
- The combined immunodetection of AP-2α and YY1 transcription factors is associated with ERBB2 gene overexpression in primary breast tumorsBreast Cancer Research, 2008
- Identification and characterization of four novel peptide motifs that recognize distinct regions of the transcription factor CP2The FEBS Journal, 2005
- Lineage-specific and ubiquitous biological roles of the mammalian transcription factor LSFGene, 2004